Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew S Bell

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Msphere|October 18, 2016
DNA from Dust: Comparative Genomics of Large DNA Viruses in Field Surveillance SamplesUtsav Pandey, Andrew S Bell, Daniel W Renner, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 17, 2005
Virulence and competitive ability in genetically diverse malaria infectionsJacobus C de Roode, Riccardo Pansini, Sandra J Cheesman, et al.
Journal of Medicinal Chemistry|September 20, 2014
Structure-based design of potent and selective Leishmania N-myristoyltransferase inhibitorsJennie A Hutton, Victor Goncalves, James A Brannigan, et al.
Chemical Biology & Drug Design|June 11, 2013
TAK1 inhibition in the DFG-out conformationIain Kilty, Martin P Green, Andrew S Bell, et al.
Acta Crystallographica. Section F, Structural Biology Communications|September 18, 2024
Ternary structure of Plasmodium vivaxN-myristoyltransferase with myristoyl-CoA and inhibitor IMP-0001173Cydni Bolling, Alex Mendez, Shane Taylor, et al.
Bioorganic & Medicinal Chemistry Letters|April 3, 2009
The discovery of potent, selective, and orally bioavailable PDE9 inhibitors as potential hypoglycemic agentsMichael P Deninno, Melissa Andrews, Andrew S Bell, et al.
Journal of Medicinal Chemistry|June 25, 2020
Novel Thienopyrimidine Inhibitors of <i>Leishmania N</i>-Myristoyltransferase with On-Target Activity in Intracellular AmastigotesAndrew S Bell, Zhiyong Yu, Jennie A Hutton, et al.
Brain, Behavior, and Immunity|April 24, 2024
PCSK9 inhibition attenuates alcohol-associated neuronal oxidative stress and cellular injuryJosephin Wagner, Lauren M Park, Partha Mukhopadhyay, et al.
Bioorganic & Medicinal Chemistry Letters|September 17, 2011
Challenges of drug discovery in novel target space. The discovery and evaluation of PF-3893787: a novel histamine H4 receptor antagonistCharles E Mowbray, Andrew S Bell, Nicholas P Clarke, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2011
Discovery of a series of potent and selective human H4 antagonists using ligand efficiency and libraries to explore structure-activity relationship (SAR)M Abid Masood, Matthew D Selby, Andrew S Bell, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Msphere|October 18, 2016
DNA from Dust: Comparative Genomics of Large DNA Viruses in Field Surveillance SamplesUtsav Pandey, Andrew S Bell, Daniel W Renner, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 17, 2005
Virulence and competitive ability in genetically diverse malaria infectionsJacobus C de Roode, Riccardo Pansini, Sandra J Cheesman, et al.
Journal of Medicinal Chemistry|September 20, 2014
Structure-based design of potent and selective Leishmania N-myristoyltransferase inhibitorsJennie A Hutton, Victor Goncalves, James A Brannigan, et al.
Chemical Biology & Drug Design|June 11, 2013
TAK1 inhibition in the DFG-out conformationIain Kilty, Martin P Green, Andrew S Bell, et al.
Acta Crystallographica. Section F, Structural Biology Communications|September 18, 2024
Ternary structure of Plasmodium vivaxN-myristoyltransferase with myristoyl-CoA and inhibitor IMP-0001173Cydni Bolling, Alex Mendez, Shane Taylor, et al.
Bioorganic & Medicinal Chemistry Letters|April 3, 2009
The discovery of potent, selective, and orally bioavailable PDE9 inhibitors as potential hypoglycemic agentsMichael P Deninno, Melissa Andrews, Andrew S Bell, et al.
Journal of Medicinal Chemistry|June 25, 2020
Novel Thienopyrimidine Inhibitors of <i>Leishmania N</i>-Myristoyltransferase with On-Target Activity in Intracellular AmastigotesAndrew S Bell, Zhiyong Yu, Jennie A Hutton, et al.
Brain, Behavior, and Immunity|April 24, 2024
PCSK9 inhibition attenuates alcohol-associated neuronal oxidative stress and cellular injuryJosephin Wagner, Lauren M Park, Partha Mukhopadhyay, et al.
Bioorganic & Medicinal Chemistry Letters|September 17, 2011
Challenges of drug discovery in novel target space. The discovery and evaluation of PF-3893787: a novel histamine H4 receptor antagonistCharles E Mowbray, Andrew S Bell, Nicholas P Clarke, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2011
Discovery of a series of potent and selective human H4 antagonists using ligand efficiency and libraries to explore structure-activity relationship (SAR)M Abid Masood, Matthew D Selby, Andrew S Bell, et al.
Pageof 6